RGNX REGENXBIO Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 6, 2026
$7,88
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,4652-Wochen-Tief
$16,0052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$427M
P/E (TTM)
-2.1
EPS (TTM)
$-3.79
Umsatz (TTM)
$174M
Ihre Abzeichen
52W-Spanne
$5–$16
Analystenbewertung
BUY
Kursziel
$24
P/E
-2.1
ROE
-137.6%
Nettogewinnmarge
-112.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
RGNX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$7.88
Marktkapitalisierung (MRQ)
$427M
P/E (TTM)
-2.1
EPS (TTM)
$-3.79
Umsatz (TTM)
$174M
ROE (TTM)
-137.6%
52W-Spanne
$5–$16
RGNX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$170M2016-12-31 → 2025-12-31
EPS$-3.762016-12-31 → 2025-12-31
Freier Cashflow$-126M2016-12-31 → 2025-12-31
Nettogewinnmarge-112.6%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | RGNX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.15-Jahres-Durchschnitt ≈-0.1 | ≈-0.1 | · | · | |
| P/S (TTM) | 2.45-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 3.7 | Fairer Wert | |
| K/B (MRQ) | 5.95-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 3.0 | Überbewertet | |
| Kurs / FCF (TTM) | -1.75-Jahres-Durchschnitt ≈-1.0 | ≈-1.0 | · | · | |
| Kurs / Cashflow (TTM) | -1.75-Jahres-Durchschnitt ≈-2.0 | ≈-2.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.95-Jahres-Durchschnitt ≈3.0 | ≈3.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | RGNX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -94.1%5-Jahres-Durchschnitt ≈-174.2% | ≈-174.2% | -47.4% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -94.6%5-Jahres-Durchschnitt ≈-174.2% | ≈-174.2% | -47.4% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | -113.8%5-Jahres-Durchschnitt ≈-179.4% | ≈-179.4% | -61.1% | Unterdurchschnittlich | |
| Nettogewinnmarge (TTM) | -112.6%5-Jahres-Durchschnitt ≈-180.0% | ≈-180.0% | -28.8% | Spitzenklasse | |
| ROA (TTM) | -40.6%5-Jahres-Durchschnitt ≈-27.6% | ≈-27.6% | -14.3% | Schwach | |
| ROE (TTM) | -137.6%5-Jahres-Durchschnitt ≈-62.5% | ≈-62.5% | -14.4% | Schwach | |
| ROIC | -156.9%5-Jahres-Durchschnitt ≈-68.7% | ≈-68.7% | -12.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | RGNX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.95-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 10.4 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 2.65-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 2.9 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | RGNX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 104.5%5-Jahres-Durchschnitt ≈41.0% | ≈41.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 14.8%5-Jahres-Durchschnitt ≈-15.2% | ≈-15.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 2.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | RGNX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.4 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 7.35-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 54.7 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$459.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
79.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $0.43 | $0.06 | 626.4% |
| 31. März 2026 | Mai 14, 2026 | $-1.72 | $-1.37 | -25.9% |
| 31. Dezember 2025 | $-1.30 | $-0.98 | -33.3% | |
| 30. September 2025 | $-1.20 | $-1.33 | 9.9% | |
| 30. Juni 2025 | $-1.38 | $-1.12 | -23.0% | |
| 31. März 2025 | $0.12 | $0.49 | -75.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $83M | $90M | $113M | $470M | $155M | $35M | $219M | $10M | $5M | $8M | $6M | |
| Cost of Revenue | · | $34M | $37M | $55M | $52M | $36M | $8M | $10M | $2M | $98.0K | $98.0K | $122.0K | |
| R&D Expense | $228M | $209M | $232M | $242M | $181M | $166M | $124M | $84M | $57M | $45M | $17M | $5M | |
| SG&A Expense | $83M | $77M | $88M | $85M | $79M | $64M | $52M | $37M | $27M | $24M | $12M | $4M | |
| Operating Expenses | $332M | $317M | $358M | $376M | $310M | $274M | $184M | $130M | $86M | $70M | $31M | $10M | |
| Operating Income | $-161M | $-233M | $-268M | $-263M | $160M | $-119M | $-149M | $88M | $-76M | $-65M | $-23M | $-4M | |
| Interest Expense | · | · | $7M | $23M | $26M | $771.0K | · | · | · | · | $20.0K | $321.0K | |
| Interest Income | $12M | $12M | $9M | $6M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-33M | $6M | $4M | $-18M | $-19M | $13M | $52M | $16M | $3M | $2M | $326.0K | $-321.0K | |
| Pretax Income | $-194M | $-227M | $-264M | $-280M | $141M | $-106M | $-97M | $104M | $-73M | $-63M | $-23M | $-4M | |
| Income Tax | $0 | $0 | $-152.0K | $-84.0K | $13M | $5M | $-3M | $4M | $0 | $-435.0K | $0 | $0 | |
| Net Income | $-194M | $-227M | $-263M | $-280M | $128M | $-111M | $-95M | $100M | $-73M | $-63M | $-23M | $-4M | |
| EPS (Basic) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $3.01 | $-2.98 | $-2.58 | $2.99 | $-2.45 | $-2.38 | · | · | |
| EPS (Diluted) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 | $-2.98 | $-2.58 | $2.73 | $-2.45 | $-2.38 | · | · | |
| Shares (Basic) | 51,573,000 | 49,509,000 | 43,734,000 | 43,152,000 | 42,438,000 | 37,281,000 | 36,690,000 | 33,427,000 | 29,878,000 | 26,409,000 | · | · | |
| Shares (Diluted) | 51,573,000 | 49,509,000 | 43,734,000 | 43,152,000 | 43,913,000 | 37,281,000 | 36,690,000 | 36,648,000 | 29,878,000 | 26,409,000 | · | · | |
| EBITDA | $-161M | $-233M | $-268M | $-263M | $160M | $-119M | $-149M | $88M | $-76M | $-65M | $-23M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $58M | $35M | $97M | $345M | $338M | $70M | $76M | $47M | $25M | $54M | $1M | |
| Short-term Investments | $196M | $177M | $241M | $268M | $112M | $137M | $227M | $244M | $114M | $65M | $60M | · | |
| Receivables | $26M | $20M | $25M | $28M | $32M | $43M | $38M | · | · | · | $2M | $805.0K | |
| Prepaid Expense | $12M | $9M | $15M | $14M | $19M | $11M | $6M | $6M | $5M | $2M | $1M | $28.0K | |
| Other Current Assets | $13M | $14M | $20M | $9M | $10M | $2M | $4M | $4M | $1M | $1M | $851.0K | · | |
| Current Assets | $281M | $278M | $335M | $416M | $519M | $531M | $345M | $338M | $168M | $93M | $118M | $3M | |
| PP&E (Net) | $105M | $118M | $132M | $142M | $132M | $56M | $29M | $29M | $14M | $9M | $538.0K | $0 | |
| PP&E (Gross) | $192M | $190M | $189M | $183M | $161M | $79M | $43M | $36M | $17M | $10M | $618.0K | · | |
| Accum. Depreciation | $87M | $72M | $57M | $41M | $29M | $23M | $14M | $7M | $3M | $624.0K | $80.0K | · | |
| Other Non-current Assets | $5M | $4M | $5M | $6M | $6M | $5M | $5M | $2M | $862.0K | $400.0K | $168.0K | · | |
| Total Assets | $453M | $466M | $574M | $833M | $1.11B | $708M | $498M | $544M | $199M | $173M | $221M | $3M | |
| Accounts Payable | $21M | $23M | $23M | $27M | $11M | $11M | $6M | $4M | $5M | $2M | $1M | $334.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $118M | $103M | $130M | $130M | $130M | $81M | $34M | $22M | $14M | $10M | $4M | $9M | |
| Capital Leases | $65M | $74M | $82M | $89M | $85M | $70M | $9M | · | · | · | · | · | |
| Other Non-current Liabilities | $638.0K | $4M | $6M | $9M | $745.0K | $524.0K | $2M | $3M | · | · | · | · | |
| Total Liabilities | $350M | $206M | $262M | $317M | $350M | $330M | $48M | $35M | $16M | $11M | $5M | $9M | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | · | |
| Retained Earnings | $-1.13B | $-932M | $-705M | $-442M | $-161M | $-289M | $-178M | $-83M | $-188M | $-115M | $-52M | $-29M | |
| AOCI | $-687.0K | $-741.0K | $-4M | $-15M | $-3M | $-360.0K | $205.0K | $-720.0K | $-715.0K | $-33.0K | $-719.0K | · | |
| Stockholders' Equity | $103M | $260M | $312M | $516M | $764M | $378M | $450M | $509M | $183M | $162M | $217M | $-18M | |
| Liabilities + Equity | $453M | $466M | $574M | $833M | $1.11B | $708M | $498M | $544M | $199M | $173M | $221M | $3M | |
| Shares Outstanding | 50,892,000 | 49,549,000 | 44,046,000 | 43,299,000 | 42,831,000 | 37,476,000 | 36,992,000 | 36,120,000 | 31,295,000 | 26,477,000 | 26,313,000 | 2,645,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $16M | $17M | $13M | $10M | $8M | $7M | $4M | $3M | $544.0K | $80.0K | $0 | |
| Stock-based Comp | $35M | $38M | $40M | $41M | $39M | $32M | $27M | $17M | $11M | $7M | $3M | $319.0K | |
| Deferred Tax | · | · | · | · | · | · | $-467.0K | · | · | $-435.0K | · | · | |
| Restructuring | $0 | $0 | $4M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-124M | $-173M | $-218M | $-207M | $219M | $-54M | $-108M | $105M | $-58M | $-49M | $-23M | $-2M | |
| CapEx | $2M | $2M | $10M | $31M | $84M | $27M | $12M | $13M | $7M | $8M | $522.0K | · | |
| Investing Cash Flow | $-16M | $103M | $191M | $-12M | $-407M | $123M | $94M | $-279M | $-5M | $19M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $190M | $82M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | $190M | $82M | · | · | · | |
| Financing Cash Flow | $117M | $93M | $-35M | $-29M | $195M | $200M | $8M | $204M | $85M | $119.0K | · | · | |
| Net Change in Cash | $-23M | $23M | $-62M | $-248M | $7M | $269M | $-6M | $30M | $22M | $-29M | $53M | $2.0K | |
| Taxes Paid | $285.0K | $-72.0K | $-142.0K | $12M | $6M | $-191.0K | $904.0K | $3M | · | · | · | · | |
| Free Cash Flow | $-126M | $-176M | $-228M | $-238M | $135M | $-81M | $-119M | $91M | $-65M | $-57M | $-23M | · | |
| Levered FCF | · | · | $-235M | $-261M | $111M | $-82M | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.1% | -1423.8% | -304.9% | · | |
| Net Margin | -113.8% | -272.5% | -292.0% | -248.7% | 27.2% | -72.0% | -268.9% | 45.7% | -704.0% | -1372.1% | -300.6% | · | |
| Pretax Margin | -113.8% | -272.5% | -292.1% | -248.7% | 30.0% | -68.6% | -276.7% | 47.6% | -704.0% | -1381.6% | · | · | |
| EBITDA Margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.1% | -1423.8% | -304.9% | · | |
| ROA | -42.2% | -43.7% | -37.5% | -28.8% | 14.0% | -18.4% | -18.2% | 26.9% | -39.4% | -31.9% | -20.3% | · | |
| ROE | -122.5% | -81.0% | -78.1% | -51.9% | 20.9% | -28.0% | -20.6% | 19.9% | -42.4% | -33.3% | -23.0% | · | |
| ROIC | -156.9% | · | -86.0% | -50.9% | 18.9% | -33.1% | -32.2% | 16.6% | -41.5% | -40.1% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.7 | 2.6 | 3.2 | 4.0 | 6.5 | 10.2 | 15.2 | 11.6 | 9.7 | 27.2 | · | |
| Quick Ratio | 2.2 | 2.5 | 2.3 | 3.0 | 3.8 | 6.4 | 8.8 | 14.4 | 11.1 | 9.3 | 26.8 | · | |
| Interest Coverage | · | · | -39.1 | -11.3 | 6.1 | -154.6 | · | · | · | · | -1156.8 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | 0.1 | 0.5 | 0.3 | 0.1 | 0.6 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 7.3 | 3.7 | 3.4 | 3.7 | 12.5 | 3.8 | · | · | · | · | 5.2 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.02 | $5.24 | $7.08 | $11.92 | $17.84 | $10.08 | $12.17 | $14.09 | $5.85 | $6.11 | $8.24 | · | |
| Revenue / Share | $3.30 | $1.68 | $2.06 | $2.61 | $10.71 | $4.15 | $0.96 | $5.96 | · | · | · | · | |
| Cash Flow / Share | $-2.40 | $-3.50 | $-4.99 | $-4.81 | $4.98 | $-1.45 | $-2.94 | $2.86 | · | · | · | · | |
| Cash / Share | $0.68 | $1.16 | $0.78 | $2.24 | $8.06 | $9.03 | $1.88 | $2.09 | $1.49 | $0.94 | $2.06 | · | |
| EPS (TTM) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 | $-2.98 | $-2.58 | $2.73 | $-2.45 | $-2.38 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 104.5% | -7.7% | -19.9% | -76.0% | 204.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | -43.8% | -16.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $83M | $90M | $113M | $470M | $155M | $35M | $219M | $10M | $5M | $8M | · | |
| Net Income TTM | $-194M | $-227M | $-263M | $-280M | $128M | $-111M | $-95M | $100M | $-73M | $-63M | $-23M | · | |
| Market Cap | $733M | $383M | $791M | $982M | $1.40B | $1.70B | $1.52B | $1.52B | $1.04B | $491M | $437M | · | |
| P/E | -3.8 | -1.7 | -3.0 | -3.5 | 11.2 | -15.2 | -15.9 | 15.4 | -13.6 | -7.8 | · | · | |
| P/S | 4.3 | 4.6 | 8.8 | 8.7 | 3.0 | 11.0 | 43.0 | 6.9 | 100.1 | 107.0 | 57.6 | · | |
| P/B | 7.1 | 1.5 | 2.5 | 1.9 | 1.8 | 4.5 | 3.4 | 3.0 | 5.7 | 3.0 | 2.0 | · | |
| P / Tangible Book | 7.1 | 1.5 | 2.5 | 1.9 | 1.8 | 4.5 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -2.2 | -3.6 | -4.7 | 6.4 | -31.4 | -14.1 | 14.5 | -17.9 | -10.1 | -19.4 | · | |
| P / FCF | -5.8 | -2.2 | -3.5 | -4.1 | 10.4 | -21.0 | -12.7 | 16.6 | -16.0 | -8.7 | -19.0 | · | |
| Earnings Yield | -26.1% | -59.4% | -33.5% | -28.7% | 8.9% | -6.6% | -6.3% | 6.5% | -7.4% | -12.8% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $108M | $6M | $30M | $30M | $21M | $89M | $21M | $24M | $22M | $16M | $29M | $20M | $19M | $31M | $27M | $33M | |
| Cost of Revenue | · | · | · | · | · | · | · | $12M | $11M | $4M | $12M | $9M | $4M | $13M | $13M | $13M | |
| R&D Expense | $56M | $57M | $60M | $56M | $60M | $53M | $50M | $54M | $49M | $55M | $58M | $60M | $59M | $63M | $63M | $61M | |
| SG&A Expense | $22M | $21M | $22M | $20M | $20M | $20M | $20M | $19M | $19M | $18M | $23M | $24M | $23M | $21M | $21M | $21M | |
| Operating Expenses | $79M | $90M | $88M | $82M | $85M | $77M | $73M | $86M | $78M | $79M | $94M | $93M | $85M | $89M | $98M | $95M | |
| Operating Income | $29M | $-83M | $-58M | $-52M | $-63M | $12M | $-51M | $-62M | $-56M | $-64M | $-65M | $-73M | $-66M | $-58M | $-71M | $-63M | |
| Interest Expense | · | · | · | · | · | · | · | · | $449.0K | $2M | $2M | $1M | $3M | · | $6M | $7M | |
| Interest Income | $1M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $4M | $2M | · | · | · | · | · | · | |
| Other Non-op | $-7M | $-7M | $-10M | $-10M | $-8M | $-6M | $182.0K | $2M | $3M | $533.0K | $3M | $1M | $-519.0K | $-2M | $-4M | $-6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-62M | $-72M | $-67M | $-60M | $-75M | $-68M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $-43.0K | $0 | $0 | |
| Net Income | $23M | $-90M | $-67M | $-62M | $-71M | $6M | $-51M | $-60M | $-53M | $-63M | $-62M | $-72M | $-67M | $-60M | $-75M | $-68M | |
| EPS (Basic) | $0.43 | $-1.72 | $-1.30 | $-1.20 | $-1.38 | $0.12 | $-0.99 | $-1.17 | $-1.05 | $-1.38 | $-1.41 | $-1.66 | $-1.53 | $-1.38 | $-1.75 | $-1.58 | |
| EPS (Diluted) | $0.43 | $-1.72 | $-1.30 | $-1.20 | $-1.38 | $0.12 | $-0.99 | $-1.17 | $-1.05 | $-1.38 | $-1.41 | $-1.66 | $-1.53 | $-1.38 | $-1.75 | $-1.58 | |
| Shares (Basic) | 52,820,000 | 52,428,000 | · | 51,689,000 | 51,483,000 | 51,362,000 | · | 50,800,000 | 50,601,000 | 45,733,000 | 43,945,000 | 43,531,000 | 43,451,000 | · | 43,251 | 43,111 | |
| Shares (Diluted) | 53,016,000 | 52,428,000 | · | 51,689,000 | 51,483,000 | 51,434,000 | · | 50,800,000 | 50,601,000 | 45,733,000 | 43,945,000 | 43,531,000 | 43,451,000 | · | 43,251 | 43,111 | |
| EBITDA | $29M | $-83M | · | $-52M | $-63M | $12M | · | $-62M | $-56M | $-64M | $-65M | $-73M | $-66M | · | $-71M | $-63M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $15M | $34M | $59M | $80M | $130M | $58M | $57M | $58M | $113M | $53M | $69M | $70M | $97M | $119M | $121M | |
| Short-term Investments | $69M | $135M | $196M | $215M | $244M | $138M | $177M | $199M | $233M | $226M | $249M | $251M | $262M | · | $264M | $282M | |
| Receivables | $107M | $10M | $26M | $25M | $20M | $18M | $20M | $24M | $23M | $16M | $28M | $21M | $19M | · | $33M | $38M | |
| Prepaid Expense | $12M | $12M | $12M | $13M | $11M | $11M | $9M | $11M | $10M | $14M | $13M | $15M | $16M | · | $15M | $16M | |
| Other Current Assets | $12M | $14M | $13M | $19M | $19M | $16M | $14M | $23M | $23M | $27M | $23M | $22M | $23M | · | $7M | $9M | |
| Current Assets | $236M | $187M | $281M | $332M | $374M | $313M | $278M | $313M | $347M | $395M | $366M | $379M | $389M | · | $437M | $465M | |
| PP&E (Net) | $98M | $102M | $105M | $108M | $111M | $114M | $118M | $121M | $124M | $128M | $136M | $139M | $142M | · | $141M | $139M | |
| PP&E (Gross) | $192M | $193M | $192M | $191M | $191M | $191M | $190M | $190M | $189M | $189M | $190M | $189M | $187M | · | $178M | $173M | |
| Accum. Depreciation | $94M | $91M | $87M | $84M | $80M | $76M | $72M | $69M | $65M | $61M | $54M | $50M | $46M | · | $37M | $34M | |
| Other Non-current Assets | $6M | $6M | $5M | $4M | $2M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $8M | · | $8M | $6M | |
| Total Assets | $387M | $342M | $453M | $525M | $581M | $491M | $466M | $519M | $569M | $629M | $634M | $682M | $748M | · | $884M | $953M | |
| Accounts Payable | $16M | $21M | $21M | $22M | $22M | $19M | $23M | $20M | $16M | $31M | $22M | $12M | $23M | · | $25M | $17M | |
| Current Liabilities | $83M | $71M | $118M | $125M | $120M | $107M | $103M | $103M | $98M | $110M | $127M | $118M | $112M | · | $124M | $115M | |
| Capital Leases | $62M | $63M | $65M | $67M | $70M | $72M | $74M | $76M | $78M | $80M | $84M | $85M | $87M | · | $85M | $86M | |
| Other Non-current Liabilities | $486.0K | $622.0K | $638.0K | $648.0K | $664.0K | $680.0K | $4M | $4M | $4M | $3M | $6M | $6M | $6M | · | $9M | $9M | |
| Total Liabilities | $315M | $321M | $350M | $364M | $367M | $217M | $206M | $218M | $221M | $239M | $271M | $277M | $283M | · | $320M | $323M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | · | $4.0K | $4.0K | |
| Retained Earnings | $-1.19B | $-1.22B | $-1.13B | $-1.06B | $-997M | $-926M | $-932M | $-881M | $-821M | $-768M | $-642M | $-580M | $-508M | · | $-382M | $-306M | |
| AOCI | $-875.0K | $-870.0K | $-687.0K | $-652.0K | $-750.0K | $-762.0K | $-741.0K | $-582.0K | $-2M | $-3M | $-7M | $-10M | $-12M | · | $-18M | $-15M | |
| Stockholders' Equity | $72M | $21M | $103M | $161M | $214M | $274M | $260M | $301M | $348M | $391M | $363M | $406M | $465M | $516M | $564M | $631M | |
| Liabilities + Equity | $387M | $342M | $453M | $525M | $581M | $491M | $466M | $519M | $569M | $629M | $634M | $682M | $748M | · | $884M | $953M | |
| Shares Outstanding | 54,164,000 | 51,617,000 | 50,892,000 | 50,619,000 | 50,389,000 | 50,117,000 | 49,549,000 | 49,534,000 | 49,317,000 | 49,043,000 | 43,991,000 | 43,621,000 | 43,465,000 | · | 43,292,000 | 43,171,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Stock-based Comp | $9M | $9M | $8M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $11M | $11M | $9M | $10M | $10M | |
| Operating Cash Flow | $-62M | $-76M | $-52M | $-56M | $-49M | $34M | $-32M | $-41M | $-45M | $-55M | $-49M | $-47M | $-81M | $-39M | $-50M | $-62M | |
| CapEx | $760.0K | $1M | $508.0K | $491.0K | $391.0K | $1M | $1M | $326.0K | $474.0K | $557.0K | $1M | $3M | $5M | $5M | $5M | $9M | |
| Investing Cash Flow | $66M | $71M | $38M | $42M | $-140M | $45M | $40M | $50M | $-268.0K | $13M | $39M | $55M | $63M | $27M | $53M | $-1M | |
| Financing Cash Flow | $18M | $-14M | $-10M | $-7M | $139M | $-6M | $-8M | $-11M | $-9M | $121M | $-5M | $-9M | $-9M | $-9M | $-5M | $-8M | |
| Net Change in Cash | $21M | $-19M | $-24M | $-21M | $-51M | $73M | $909.0K | $-1M | $-55M | $78M | $-16M | $-1M | $-27M | $-22M | $-3M | $-70M | |
| Free Cash Flow | · | $-77M | · | · | · | $33M | · | · | · | $-56M | · | · | $-86M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.1% | -1304.0% | · | -176.3% | -296.3% | 13.6% | · | -256.6% | -251.3% | -408.8% | -224.7% | -366.0% | -345.7% | · | -268.0% | -191.5% | |
| Net Margin | 21.0% | -1408.6% | · | -208.3% | -331.8% | 6.8% | · | -246.3% | -237.7% | -405.4% | -214.0% | -360.7% | -348.4% | · | -284.7% | -208.8% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -214.0% | -360.7% | -348.4% | · | -284.7% | -208.8% | |
| EBITDA Margin | 27.1% | -1304.0% | · | -176.3% | -296.3% | 13.6% | · | -256.6% | -251.3% | -408.8% | -224.7% | -366.0% | -345.7% | · | -268.0% | -191.5% | |
| ROA | 4.7% | -21.6% | · | -11.9% | -12.3% | 1.1% | · | -10.3% | -8.5% | -9.2% | -8.2% | -8.8% | -7.5% | · | -9.0% | -7.6% | |
| ROE | 15.9% | -61.0% | · | -26.8% | -25.2% | 1.8% | · | -17.9% | -14.1% | -14.8% | -13.4% | -13.9% | -11.6% | · | -14.7% | -12.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.6 | · | 2.7 | 3.1 | 2.9 | · | 3.1 | 3.5 | 3.6 | 2.9 | 3.2 | 3.5 | · | 3.5 | 4.1 | |
| Quick Ratio | 2.6 | 2.3 | · | 2.4 | 2.9 | 2.7 | · | 2.7 | 3.2 | 3.2 | 2.6 | 2.9 | 3.1 | · | 3.4 | 3.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -124.8 | -32.4 | -40.0 | -65.3 | -24.0 | · | -11.9 | -9.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.1 | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | 1.7 | 0.5 | · | 1.2 | 1.0 | 5.2 | · | 0.9 | 1.0 | 0.9 | 1.0 | 0.7 | 0.8 | · | 0.7 | 0.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.32 | $0.41 | · | $3.19 | $4.24 | $5.47 | · | $6.08 | $7.06 | $7.97 | $8.25 | $9.30 | $10.70 | · | $13.02 | $14.61 | |
| Revenue / Share | $2.04 | $0.12 | · | $0.58 | $0.41 | $1.73 | · | $0.48 | $0.44 | $0.34 | $657.96 | $458.91 | $440.45 | · | $612.98 | $757.32 | |
| Cash Flow / Share | · | $-1.45 | · | · | · | $0.65 | · | · | · | $-1.21 | · | · | $-1862.28 | · | · | · | |
| Cash / Share | $0.67 | $0.29 | · | $1.16 | $1.58 | $2.60 | · | $1.14 | $1.17 | $2.30 | $1.21 | $1.57 | $1.61 | · | $2.74 | $2.81 | |
| EPS (TTM) | $-3.79 | $-5.60 | · | $-3.45 | $-3.42 | $-3.09 | · | · | · | · | $-5.98 | $-6.32 | $-6.24 | · | $1.72 | $2.10 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $174M | $88M | · | $161M | $156M | $157M | · | · | · | · | $99M | $97M | $110M | · | $480M | $484M | |
| Net Income TTM | $-196M | $-290M | · | $-178M | $-176M | $-158M | · | · | · | · | $-261M | $-274M | $-270M | · | $74M | $91M | |
| Market Cap | $649M | $433M | · | $488M | $414M | $358M | · | $520M | $577M | $1.03B | $724M | $872M | $822M | · | $1.14B | $1.07B | |
| P/E | -3.2 | -1.5 | · | -2.8 | -2.4 | -2.3 | · | · | · | · | -2.8 | -3.2 | -3.0 | · | 15.4 | 11.8 | |
| P/S | 3.7 | 4.9 | · | 3.0 | 2.7 | 2.3 | · | · | · | · | 7.3 | 9.0 | 7.5 | · | 2.4 | 2.2 | |
| P/B | 9.0 | 20.5 | · | 3.0 | 1.9 | 1.3 | · | 1.7 | 1.7 | 2.6 | 2.0 | 2.1 | 1.8 | · | 2.0 | 1.7 | |
| P / Tangible Book | 9.0 | 20.5 | · | 3.0 | 1.9 | 1.3 | · | 1.7 | 1.7 | 2.6 | 2.0 | 2.1 | 1.8 | · | 2.0 | 1.7 | |
| P / Cash Flow | · | -5.7 | · | · | · | 10.7 | · | · | · | -18.6 | · | · | -10.2 | · | · | · | |
| Earnings Yield | -31.6% | -66.8% | · | -35.8% | -41.7% | -43.2% | · | · | · | · | -36.3% | -31.6% | -33.0% | · | 6.5% | 8.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $170M | $83M | $90M | $113M | $470M |
| Betriebsgewinnmarge % | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% |
| Nettoergebnis | $-194M | $-227M | $-263M | $-280M | $128M |
| Verwässerte EPS | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.4 | 2.7 | 2.6 | 3.2 | 4.0 |
| Quick Ratio | 2.2 | 2.5 | 2.3 | 3.0 | 3.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-126M | $-176M | $-228M | $-238M | $135M |
Institutionelle Eigentümer (13F) 188 Einreicher · $564.6M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
188
Gehaltener Wert
$564.6M
Neue Positionen
27
Geschlossene Positionen
31
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (-14 vs. Vorquartal) | 31 (+5 vs. Vorquartal) | 65 (+3 vs. Vorquartal) | 55 (+1 vs. Vorquartal) | +67K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $76.641.333 | 6.397.440 | 13,57% | Aktien |
| Redmile Group, LLC | $52.338.272 | 4.368.804 | 9,27% | Aktien |
| VANGUARD GROUP INC | $48.587.616 | 3.374.140 | 8,61% | Aktien |
| STATE STREET CORP | $35.594.653 | 2.971.173 | 6,30% | Aktien |
| JPMORGAN CHASE & CO | $26.193.619 | 2.214.169 | 4,64% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $25.248.533 | 2.107.557 | 4,47% | Aktien |
| MORGAN STANLEY | $23.399.786 | 1.953.237 | 4,14% | Aktien |
| GOLDMAN SACHS GROUP INC | $17.029.007 | 1.421.453 | 3,02% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $16.512.730 | 1.378.358 | 2,92% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16.239.537 | 1.355.554 | 2,88% | Aktien |
| MARSHALL WACE, LLP | $15.393.701 | 1.284.950 | 2,73% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $14.874.704 | 1.241.296 | 2,63% | Aktien |
| Integral Health Asset Management, LLC | $9.584.000 | 800.000 | 1,70% | Aktien |
| Nuveen, LLC | $8.865.511 | 740.026 | 1,57% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $8.763.715 | 731.586 | 1,55% | Aktien |
| D. E. Shaw & Co., Inc. | $8.539.512 | 712.814 | 1,51% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $8.024.300 | 669.808 | 1,42% | Aktien |
| CITADEL ADVISORS LLC | $8.014.896 | 669.023 | 1,42% | Aktien |
| STIFEL FINANCIAL CORP | $6.717.524 | 560.727 | 1,19% | Aktien |
| BANK OF AMERICA CORP /DE/ | $6.212.169 | 518.545 | 1,10% | Aktien |
| 22NW, LP | $5.903.253 | 492.759 | 1,05% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.759.529 | 480.762 | 1,02% | Aktien |
| Pale Fire Capital SE | $5.585.184 | 466.209 | 0,99% | Aktien |
| NORTHERN TRUST CORP | $5.053.632 | 421.839 | 0,90% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.749.471 | 396.450 | 0,84% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $4.437.093 | 370.375 | 0,79% | Aktien |
| FMR LLC | $4.107.444 | 342.858 | 0,73% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.039.165 | 337.159 | 0,72% | Aktien |
| Quantinno Capital Management LP | $3.595.521 | 300.127 | 0,64% | Aktien |
| GSK plc | $3.252.043 | 271.456 | 0,58% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.173.646 | 264.912 | 0,56% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $3.075.098 | 256.686 | 0,54% | Aktien |
| JANE STREET GROUP, LLC | $3.036.846 | 253.493 | 0,54% | Aktien |
| UBS Group AG | $2.994.365 | 249.947 | 0,53% | Aktien |
| Jump Financial, LLC | $2.871.606 | 239.700 | 0,51% | Aktien |
| Hudson Bay Capital Management LP | $2.695.500 | 225.000 | 0,48% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.669.144 | 222.800 | 0,47% | Kaufoption |
| ArchPoint Investors | $2.662.890 | 222.278 | 0,47% | Aktien |
| Corient Private Wealth LP | $2.607.580 | 217.661 | 0,46% | Aktien |
| DEUTSCHE BANK AG\ | $2.489.864 | 207.835 | 0,44% | Aktien |
| Walleye Capital LLC | $2.440.637 | 203.726 | 0,43% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $2.174.023 | 181.471 | 0,39% | Aktien |
| Assenagon Asset Management S.A. | $2.027.962 | 169.279 | 0,36% | Aktien |
| Aquilo Capital Management, LLC | $1.939.809 | 271.302 | 0,34% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.785.000 | 149.000 | 0,32% | Aktien |
| IEQ CAPITAL, LLC | $1.694.798 | 141.469 | 0,30% | Aktien |
| Bank of New York Mellon Corp | $1.607.650 | 134.194 | 0,28% | Aktien |
| Invesco Ltd. | $1.603.535 | 133.851 | 0,28% | Aktien |
| Russell Investments Group, Ltd. | $1.453.879 | 121.359 | 0,26% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.431.263 | 119.471 | 0,25% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Allan M. Fox | 18. September 2020 | · | Erste Einreichung | Passive Anlage | SEC |
| The Allan M. Fox Trust (U/A/D April 21, 2015), The Allan M. Fox Revocable Trust, FoxKiser Holdings, LLC | 25. September 2015 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 9 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Curran Simpson | Chief Executive Officer | 1. Juli 2026 F | 338.053 | 0 | 1 | $-262.635 |
| Mitchell Chan | Chief Financial Officer | 1. September 2026 F | 122.815 | 0 | 0 | $0 |
| Vittal Vasista | Chief Financial Officer | 19. März 2024 M | 246.534 | 0 | 0 | $0 |
| Craig Malzahn | Chief Technology Officer | 1. September 2026 F | 81.960 | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 1. August 2026 F | 205.541 | 0 | 5 | $-939.970 |
| Patrick J. Christmas | Chief Strategy & Legal Officer | 1. August 2026 F | 205.968 | 0 | 0 | $0 |
| Olivier Danos | Chief Scientific Officer | 1. Februar 2025 F | 226.348 | 0 | 0 | $0 |
| Stephen Yoo | Chief Medical Officer | 3. Dezember 2018 M | 0 | 0 | 0 | $0 |
| Faraz Ali | Chief Business Officer | 4. Januar 2017 A | · | 0 | 0 | $0 |
| Gregory A. Ciongoli | Direktor | 25. August 2026 A | 118.035 | 2 | 0 | $949.541 |
| Jean Bennett | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| Jennifer Zachary | Direktor | 29. Mai 2026 A | 31.871 | 0 | 0 | $0 |
| Alexandra Glucksmann | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| Allan M. Fox | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| Kenneth T. Mills | Direktor | 29. Mai 2026 A | 495.925 | 0 | 0 | $0 |
| Daniel Tasse | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| David C Stump | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| Argeris N Karabelas | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| George V Migausky | Direktor | 29. Mai 2026 A | 28.861 | 0 | 0 | $0 |
| Daniel Abdun-Nabi | Direktor | 4. Juni 2021 A | · | 0 | 0 | $0 |
| Luke M Beshar | Direktor | 4. Juni 2021 A | 0 | 0 | 0 | $0 |
| Donald J Hayden JR | Direktor | 29. Mai 2020 A | 0 | 0 | 0 | $0 |
| Camille D Samuels | Direktor | 1. Juni 2016 A | · | 0 | 0 | $0 |
| Edgar Engleman | Direktor | 22. September 2015 C | 114.108 | 0 | 0 | $0 |
| FMR LLC | · | 17. Mai 2016 J | 489.880 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 27 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,97% | 46.670 NS | 31. Juli 2026 | N-PORT |
| IBRN · iShares Trust | 0,42% | 3.665 SH | 11. September 2026 | Täglich |
| HAPS · Harbor ETF Trust | 0,19% | 33.948 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,13% | 66.560 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 445.369 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,04% | 909 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 119.850 SH | 2. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 4.662 SH | 2. Oktober 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 42.944 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 378.118 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 277.538 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 23.065 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.247.225 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 564.284 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7.033 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 130.035 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 145.383 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.300 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4.800 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.755 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 101.339 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 12.166 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.524 SH | 3. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 2.500 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.496.139 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.625 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 73.037 SH | 11. September 2026 | Täglich |
RGNX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$19.00
+141,1%
6 31,6%
Starker Kauf
10 52,6%
Kauf
3 15,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-09-30Mittelwert-Ziel $23.73 +201,1%
← Unter allen Zielen
Aktueller Preis $7.88
Tief$10.00
Mittelwert$23.73
Hoch$50.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026